Selective Cu(I) complex with phosphine-peptide (SarGly) conjugate contra breast cancer: Synthesis, spectroscopic characterization and insight into cytotoxic action

Chemotherapy is still one of the major approaches to treat cancer. However, the main disadvantage of conventional chemotherapy is the inability to deliver the correct amount of drug directly to cancer cells without affecting healthy cells. Cytotoxic copper(I) complexes connected with phosphine-peptide conjugate as a carrier can improve selective transport.206